Fletcher Spaght Ventures is a venture capital and private equity firm investing in healthcare, life science, and information technology companies that is headquartered in Boston, Massachusetts and was founded in 2001 by John Fletcher and Linda Tufts.
As of December 2019, Fletcher Spaght Ventures has made 37 investments, has 9 companies in its portfolio, and made a total of 19 exits. Notable investments made by Fletcher Spaght Ventures include: PhaseBio Pharmaceuticals, Swift Biosciences, HTG Molecular Diagnostics, Cadent, Biocius Life Sciences, HistoSonics, CardioFocus, Cheetah Medical, SurgiQuest, Cayenne Medical, and BioTrove.
Metabolon is a company developing metabolomics analytical methods and software for biomarker discovery
Juventas Therapeutics is a biotechnology company founded in 2007 that is headquartered in Cleveland, Ohio developing a pipeline of regenerative therapies to treat life-threatening diseases.
SurgiQuest is a surgical device company focusing on technologies for minimally-invasive procedures; the company was acquired by CONMED in 2015.
A diagnostics company developing automated sample processing
A biopharmaceutical company that develops drugs for the treatment of cardiovascular diseases, endocrine and other metabolic disorders